Bruno Francois Jules Angelici
Vorsitzender bei Vectura GmbH
Aktive Positionen von Bruno Francois Jules Angelici
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Vorsitzender | - | - |
Karriereverlauf von Bruno Francois Jules Angelici
Ehemalige bekannte Positionen von Bruno Francois Jules Angelici
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VECTURA GROUP | Direktor/Vorstandsmitglied | 01.12.2013 | 01.02.2014 |
| Vorsitzender | 01.02.2014 | 19.10.2021 | |
| Independent Dir/Board Member | 01.12.2013 | - | |
| SMITHS GROUP PLC | Direktor/Vorstandsmitglied | 01.07.2010 | 16.11.2020 |
| Independent Dir/Board Member | 01.07.2010 | 16.11.2020 | |
| WOLTERS KLUWER N.V. | Direktor/Vorstandsmitglied | 20.04.2007 | 18.04.2019 |
| Independent Dir/Board Member | 20.04.2007 | 18.04.2019 | |
| NOVO NORDISK A/S | Direktor/Vorstandsmitglied | 11.08.2011 | 23.03.2017 |
| Independent Dir/Board Member | 11.08.2011 | 23.03.2017 | |
| ASTRAZENECA PLC | Vertrieb & Marketing | 31.12.2009 | 31.12.2009 |
Astrazeneca Japan Ltd.
 Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | Präsident | 01.01.1998 | - |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - | - |
Astra Zeneca Holding France SAS
 Astra Zeneca Holding France SAS Pharmaceuticals: MajorHealth Technology Astra Zeneca Holding France SAS operates as a holding firm with interest in pharmaceuticals. The company was founded in 1994 and is headquartered in Rueil-Malmaison, France. | Präsident | - | - |
Ausbildung von Bruno Francois Jules Angelici
| University of Reims Champagne-Ardenne | Graduate Degree |
| Ecole Supérieure de Commerce de Reims | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistik
International
| Vereinigtes Königreich | 4 |
| Frankreich | 4 |
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 4 |
| Independent Dir/Board Member | 4 |
| President | 2 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 4 |
| Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| WOLTERS KLUWER N.V. | Technology Services |
| SMITHS GROUP PLC | Producer Manufacturing |
| ASTRAZENECA PLC | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Astrazeneca Japan Ltd.
Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | Health Services |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Health Technology |
Astra Zeneca Holding France SAS
Astra Zeneca Holding France SAS Pharmaceuticals: MajorHealth Technology Astra Zeneca Holding France SAS operates as a holding firm with interest in pharmaceuticals. The company was founded in 1994 and is headquartered in Rueil-Malmaison, France. | Health Technology |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
